ICTUImperial Clinical Trials Unit

Welcome to Imperial Clinical Trials Unit (ICTU)

This website is intended for commercial trial sponsors engaged in the area of pharmaceuticals, medical devices or diagnostic devices

About ICTU

The information on this page is for commercial Sponsors interested in working with ICTU on the design and execution of clinical trials.

Imperial College users and academic researchers, please go to the ICTU academic homepage

If you are an individual interested in taking part in clinical trials, please go to our Trial Participant page.

Overview

Imperial Clinical Trials Unit (ICTU) is an academic research unit based at Imperial College London. Our mission is to deliver excellence in the design, conduct and dissemination of clinical trials of all phases and through this to deliver major local, national and international health benefits for patients.

ICTU conducts interventional trials in the following fields: drug (phase I-IV); medical devices; nutrition/lifestyle and surgery. It also conducts observational and population studies along with the assessment of diagnostic devices.

While the focus of ICTU's activity is high-quality academic research, in particular randomised controlled trials, it also collaborates with pharmaceutical and device companies in conducting research of significant clinical relevance and/or exploring novel/innovative therapies. ICTU’s role can include all stages of clinical development from advising on unmet medical needs in a therapeutic area, designing, co-ordinating or monitoring international studies to the analysis and communication of study findings. 

ICTU became a fully registered member of the UK Clinical Research Collaboration (UKCRC) in Aug 2012.